Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.

MLA

Luedeke, Manuel, et al. “Prostate Cancer Risk Regions at 8q24 and 17q24 Are Differentially Associated with Somatic TMPRSS2:ERG Fusion Status.” Human Molecular Genetics, vol. 25, no. 24, Dec. 2016, pp. 5490–99. EBSCOhost, https://doi.org/10.1093/hmg/ddw349.

APA

Luedeke, M., Rinckleb, A. E., FitzGerald, L. M., Geybels, M. S., Schleutker, J., Eeles, R. A., Teixeira, M. R., Cannon-Albright, L., Ostrander, E. A., Weikert, S., Herkommer, K., Wahlfors, T., Visakorpi, T., Leinonen, K. A., Tammela, T. L. J., Cooper, C. S., Kote-Jarai, Z., Edwards, S., Goh, C. L., … Maier, C. (2016). Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human Molecular Genetics, 25(24), 5490–5499. https://doi.org/10.1093/hmg/ddw349

Chicago

Luedeke, Manuel, Antje E Rinckleb, Liesel M FitzGerald, Milan S Geybels, Johanna Schleutker, Rosalind A Eeles, Manuel R Teixeira, et al. 2016. “Prostate Cancer Risk Regions at 8q24 and 17q24 Are Differentially Associated with Somatic TMPRSS2:ERG Fusion Status.” Human Molecular Genetics 25 (24): 5490–99. doi:10.1093/hmg/ddw349.